SCHEMBL4933189

SCHEMBL4933189

O=[N+]([O-])c1cc(Cl)c(Cl)cc1Nc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MERTK Q12866 1/20 0.51
MAPT P10636 6/20 0.46
MAPK1 P28482 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
TDP1 Q9NUW8 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
MITF O75030 1/20 0.46
TP53 P04637 1/20 0.44
CASP3 P42574 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
POLB P06746 1/20 0.44
AKR1C3 P42330 1/20 0.43
AKR1C2 P52895 1/20 0.43
ALDH3A1 P30838 3/20 0.42
EPAS1 Q99814 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4926422 0.86 L3MBTL1 (0.49) MERTKMAPTMAPK1L3MBTL1TDP1
SCHEMBL4922797 0.86 L3MBTL1 (0.63) MAPTMAPK1L3MBTL1TDP1ALDH1A1
SCHEMBL4932198 0.84 MERTK (0.51) MERTKMAPTMAPK1L3MBTL1TDP1
SCHEMBL4933766 0.82 MAPT (0.67) MERTKMAPTMAPK1L3MBTL1TDP1
SCHEMBL17582857 0.81 MAPK1 (0.56) MAPTMAPK1L3MBTL1TDP1ALDH1A1
SCHEMBL3918265 0.80 MAPK1 (0.62) MAPTMAPK1L3MBTL1TDP1ALDH1A1
SCHEMBL4931104 0.79 MAPT (0.58) MERTKMAPTMAPK1L3MBTL1TDP1
SCHEMBL2278730 0.78 MERTK (0.53) MERTKMAPTMAPK1L3MBTL1TDP1
SCHEMBL16429768 0.77 L3MBTL1 (0.58) MAPTMAPK1L3MBTL1TDP1ALDH1A1
SCHEMBL8619524 0.77 L3MBTL1 (0.69) MERTKMAPTMAPK1L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080021069-A1 Receptor Function Regulating Agent TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-24 US disclosed
EP-1810677-A1 RECEPTOR FUNCTION REGULATING AGENT Takeda Pharmaceutical Company Limited (JP) 2007-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021069-A1 Receptor Function Regulating Agent GPR119, INSR, GPR65 MERTK 940/4885MAPT 4574/4885MAPK1 884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.